Aspen Aerogels Q2 2024 Adj. EPS $0.03 Misses $0.05 Estimate, Sales $117.800M Beat $101.200M Estimate
Portfolio Pulse from Benzinga Newsdesk
Aspen Aerogels (NYSE:ASPN) reported Q2 2024 earnings per share of $0.03, missing the analyst estimate of $0.05 by 40%. However, the company reported sales of $117.8 million, beating the estimate of $101.2 million by 16.4% and marking a 144.61% increase from the same period last year.
August 07, 2024 | 8:53 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Aspen Aerogels reported mixed Q2 2024 results with EPS missing estimates by 40% but sales beating expectations by 16.4% and showing a significant YoY increase.
The mixed results, with a significant sales beat but an EPS miss, are likely to create a neutral short-term impact on the stock price. Investors may weigh the strong revenue growth against the EPS miss.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100